Related Experiment Video
Updated: Aug 29, 2025

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats
Published on: March 8, 2019
Massive Haemoptysis Treated with Bronchial Artery Embolisation in COVID-19 Infection
Islam Mejri1, Nouha Boubaker1, Tasnim Znegui1
1Pneumology Department, Military Hospital, Tunis, Tunisia.
Background:
Massive haemoptysis is a rare symptom ofcoronavirus disease 2019 (COVID-19). Management can be very challenging due to the lack of clear recommendations.
Case Description:
We report a case of massive recurrent haemoptysis in a young patient who tested positive for COVID-19 with successful management using endovascular embolization.
Discussion:
Life-threatening massive haemoptysis has rarely been reported as the only manifestation of COVID-19. Embolisation was the therapeutic option chosen to manage this emergency.
Learning Points:
Haemoptysis is a rare atypical presentation that can reveal COVID-19, highlighting the complexity of its pathogenesis.Atypical manifestations should raise suspicion for COVID-19.In this patient with COVID-19, life-threatening massive haemoptysis was successfully treated with endovascular embolisation.
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
COPD: Management Using Bronchodilators and Corticosteroids
Pulmonary Embolism I: Introduction
Pulmonary Embolism III: Nursing Management
Pneumothorax-II
Clinical Manifestations:
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...

